Related Experiment Video
Updated: Feb 15, 2026

Tachycardia-Induced Cardiomyopathy As a Chronic Heart Failure Model in Swine
Published on: February 17, 2018
Myocarditis in Paediatric Patients: Unveiling the Progression to Dilated Cardiomyopathy and Heart Failure
Inês Teixeira Farinha1, Joana Oliveira Miranda2,3
1Faculty of Medicine of Porto University, Porto 4200-319, Portugal. i.t.farinha@gmail.com.
Insights
Pediatric myocarditis, an inflammation of the heart muscle, can lead to dilated cardiomyopathy. This review explores recent discoveries in pediatric myocarditis, aiding diagnosis and treatment strategies.
Area of Science:
- Cardiology
- Pediatric Medicine
- Pathology
Background:
- Myocarditis presents a significant health challenge in children, potentially causing severe illness and progressing to dilated cardiomyopathy.
- Diverse causes exist, with viral infections being most common in developed nations, though bacterial, protozoal infections, and drug hypersensitivity are also implicated.
- Diagnosing pediatric myocarditis is complex due to a wide range of clinical presentations, from asymptomatic cases to sudden cardiac death.
Purpose of the Study:
- To review recent advancements in understanding pediatric myocarditis.
- To explore the disease's progression to dilated cardiomyopathy.
- To discuss updated diagnostic and therapeutic approaches.
Main Methods:
- Literature review focusing on recent studies of pediatric myocarditis.
- Analysis of diagnostic modalities including endomyocardial biopsy and non-invasive tools.
- Examination of treatment strategies, including the role of intravenous immunoglobulin.
Main Results:
- Myocarditis pathogenesis exhibits a triphasic nature, influencing management strategies.
- Endomyocardial biopsy is the definitive diagnostic standard, supported by various non-invasive methods.
- The efficacy of intravenous immunoglobulin in treating pediatric myocarditis remains under investigation.
Conclusions:
- Understanding the triphasic nature of myocarditis is crucial for effective patient management.
- Accurate diagnosis relies on a combination of biopsy and non-invasive techniques.
- Further research is needed to clarify treatment outcomes, particularly for intravenous immunoglobulin therapy in pediatric cases.
Abstract:
Myocarditis is a challenging and potentially life-threatening disease associated with high morbidity in some paediatric patients, due to its ability to present as an acute and fulminant disease and to ultimately progress to dilated cardiomyopathy. It has been described as an inflammatory disease of the myocardium caused by diverse aetiologies. Viral infection is the most frequent cause of myocarditis in developed countries, but bacterial and protozoal infections or drug hypersensitivity may also be causative agents. The prompt diagnosis in paediatric patients is difficult, as the spectrum of clinical manifestation can range from no myocardial dysfunction to sudden cardiac death. Recent studies on myocarditis pathogenesis have revealed a triphasic nature of this disease, which influences the diagnostic and therapeutic strategies to adopt in each patient. Endomyocardial biopsy remains the gold standard for diagnosing myocarditis, and several non-invasive diagnostic tools can be used to support the diagnosis. Intravenous immunoglobulin has become part of routine practice in the treatment of myocarditis in paediatric patients at many centres, but its true effect on the cardiac function has been the target of many studies. The aim of this review is to approach the recently discovered facets of paediatric myocarditis regarding its progression to dilated cardiomyopathy.
Related Concept Videos
Cardiomyopathy II: Dilated Cardiomyopathy
Heart Failure II: Pathophysiology
Pathophysiology of Heart Failure
Heart Failure I: Introduction
Heart Failure VI: Adjunct Therapies
Heart Failure Drugs: Diuretics

